Milestone Pharmaceuticals, Inc. (MIST)
0.765
+0.05
(+7.43%)
USD |
NASDAQ |
Oct 09, 16:00
0.765
0.00 (0.00%)
After-Hours: 20:00
Milestone Pharmaceuticals Free Cash Flow (Quarterly) : -22.56M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.56M |
| March 31, 2026 | -16.10M |
| December 31, 2025 | -12.60M |
| September 30, 2025 | -9.840M |
| June 30, 2025 | -13.04M |
| March 31, 2025 | -13.96M |
| December 31, 2024 | -6.334M |
| September 30, 2024 | -7.042M |
| June 30, 2024 | -5.954M |
| March 31, 2024 | -8.934M |
| December 31, 2023 | -9.252M |
| September 30, 2023 | -12.25M |
| June 30, 2023 | -10.68M |
| March 31, 2023 | -13.94M |
| December 31, 2022 | -11.51M |
| Date | Value |
|---|---|
| September 30, 2022 | -11.08M |
| June 30, 2022 | -14.03M |
| March 31, 2022 | -13.95M |
| December 31, 2021 | -12.29M |
| September 30, 2021 | -9.121M |
| June 30, 2021 | 0.8371M |
| March 31, 2021 | -12.47M |
| December 31, 2020 | -9.679M |
| September 30, 2020 | -8.406M |
| June 30, 2020 | -16.06M |
| March 31, 2020 | -18.08M |
| December 31, 2019 | -16.71M |
| September 30, 2019 | -8.939M |
| June 30, 2019 | -11.45M |
| March 31, 2019 | -14.73M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -2.909M |
| NervGen Pharma Corp. | -4.086M |
| Clearmind Medicine, Inc. | -1.859M |
| Lexaria Bioscience Corp. | -1.661M |
| Target Group, Inc. (Canada) | -0.2294M |